Cite
HARVARD Citation
Fleisher, C. et al. (n.d.). Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder. Expert opinion on investigational drugs. pp. 1157-1163. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fleisher, C. et al. (n.d.). Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder. Expert opinion on investigational drugs. pp. 1157-1163. [Online].